Videos
•
Why venture capital investment is vital to the growth and success of the European pharmaceuticals industry, which supports tens of millions of people every year through the development of new treatments.
Big money to invest push this acceleration and the growth of these drugs and this company.
I am Dr Rafaèle Tordjman, founder and C of jto capital a European fund private Equity Fund in healthcare and biotech. My passion is how to benefit patients in term of new drugs and accelerating this assets to new drugs.
We are targeting the Pharma demand indeed farmer are fulfilling their pipeline because of a loss of patent, it is estimated by 2030 they will lose for 300 billions of revenues because of this loss of pattern so they acquired smaller companies that we Finance at a stage of development not yet in commercialization but with very big value potential billions and it's not a bubble it's related to a value of the future projected cells these farmer are sitting on 1.7 trillions when you look at the first 25 .
First Farmer and the need is Without End two thir of the disease without treatment efficacious and uh you know even new new disase so it's without cycle without bubble always a liquidity possibility even when the market the public market are closed uh even when the micro environment is not good because you have always patient that are desperated to get new drugs an investor that should have like jto big money to invest pushes accelerate and the growth of these drugs and this company to make the maximum and the earliest way the benefit to the patient that will drive the financial performance
World Health Day: life-changing investments
Opinion
06 Apr 2023
New Invest Europe report highlights venture capital’s role in supporting pioneering European life sciences start-ups
Press releases
13 Oct 2022
The European Life Sciences Coalition (ELSC): Empowering the next generation of life-saving breakthroughs (Video)
Videos
05 Jun 2026
MEMBER ONLY
Venture capital and private equity investors’ impact on the growth and sustainability of Finnish companies
External resources
30 Sep 2025
Position Paper on Biotech & Healthcare
Positions & consultation responses
03 Nov 2025
MEMBER ONLY
Global Healthcare Private Equity Report 2024
External resources
03 Jan 2024
MEMBER ONLY
Association Between Hospital Private Equity Acquisition and Outcomes of Acute Medical Conditions Among Medicare Beneficiaries
External resources
29 Apr 2022
MEMBER ONLY
Financial Impacts And Operational Implications Of Private Equity Acquisition Of US Hospitals
External resources
01 Apr 2022
MEMBER ONLY
Private Equity Acquisition And Responsiveness To Service-Line Profitability At Short-Term Acute Care Hospitals
External resources
01 Nov 2021
MEMBER ONLY
Private Equity Investments In Health Care: An Overview Of Hospital And Health System Leveraged Buyouts, 2003–17
External resources
01 May 2021
MEMBER ONLY
Does Private Equity Investment in Healthcare Benefit Patients? Evidence from Nursing Homes
External resources
01 Feb 2021
MEMBER ONLY
Comparative Performance of Private Equity–Owned US Nursing Homes During the COVID-19 Pandemic
External resources
28 Oct 2020
European Life Sciences Roundtable: Advancing Europe's Biotech Competitiveness
News
25 Jun 2026
Europe’s Choice: The value of investing in innovation
External events
23 Jun 2026
MEMBER ONLY
How innovation drives health and growth in Europe: Assessing the Return on Investment of innovative medicines
External resources
23 Jun 2026